journal article·2014-10Open access

Human embryonic stem cells and macroporous calcium phosphate construct for bone regeneration in cranial defects in rats

Xian Liu, Ping Wang, Wenchuan Chen, Michael D. Weir, Chongyun Bao, Hockin H.K. Xu

Acta Biomaterialia· Volume 10· Issue 10

Abstract

Human embryonic stem cells (hESCs) are an exciting cell source as they offer an unlimited supply of cells that can differentiate into all cell types for regenerative medicine applications. To date, there has been no report on hESCs with calcium phosphate cement (CPC) scaffolds for bone regeneration in vivo. The objectives of this study were to: (i) investigate hESCs for bone regeneration in vivo in critical-sized cranial defects in rats; and (ii) determine the effects of cell seeding and platelets in macroporous CPC on new bone and blood vessel formation. hESCs were cultured to yield mesenchymal stem cells (MSCs), which underwent osteogenic differentiation. Four groups were tested in rats: (i) CPC control without cells; (ii) CPC with hESC-derived MSCs (CPC+hESC-MSC); (iii) CPC with hESC-MSCs and 30% human platelet concentrate (hPC) (CPC+hESC-MSC+30% hPC); and (iv) CPC+hESC-MSC+50% hPC. In vitro, MSCs were derived from embryoid bodies of hESCs. Cells on CPC were differentiated into the osteogenic lineage, with highly elevated alkaline phosphatase and osteocalcin expressions, as well as mineralization. At 12weeks in vivo, the groups with hESC-MSCs and hPC had three times as much new bone as, and twice the blood vessel density of, the CPC control. The new bone in the defects contained osteocytes and blood vessels, and the new bone front was lined with osteoblasts. The group with 30% hPC and hESC-MSCs had a blood vessel density that was 49% greater than the hESC-MSC group without hPC, likely due to the various growth factors in the platelets enhancing both new bone and blood vessel formation. In conclusion, hESCs are promising for bone tissue engineering, and hPC can enhance new bone and blood vessel formation. Macroporous CPC with hESC-MSCs and hPC may be useful for bone regeneration in craniofacial and orthopedic applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (71)

Show source-provided references
1. Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives10.5966/sctm.2011-0036 ↗
2. Bone tissue engineering and regeneration: from discovery to the clinic – an overview10.1089/ten.teb.2011.0475 ↗
3. Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles10.1177/0022034509341553 ↗
4. Extracellular matrix protein adsorption to phosphate-functionalized gels from serum promotes osteogenic differentiation of human mesenchymal stem cells10.1016/j.actbio.2012.09.007 ↗
5. Repair of osteochondral defects with rehydrated freeze-dried oligo[poly(ethylene glycol) fumarate] hydrogels seeded with bone marrow mesenchymal stem cells in a porcine model10.1089/ten.tea.2012.0621 ↗
6. Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects10.1089/ten.tea.2010.0471 ↗
7. Perspectives on the role of nanotechnology in bone tissue engineering10.1016/j.dental.2012.08.001 ↗
8. Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head10.1186/scrt98 ↗
9. Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs10.1002/adma.201201762 ↗
10. Nanofiber scaffold gradients for interfacial tissue engineering10.1177/0885328211423783 ↗
11. Scaffold/extracellular matrix hybrid constructs for bone-tissue engineering10.1002/adhm.201200209 ↗
12. Cell mediated contraction in 3D cell–matrix constructs leads to spatially regulated osteogenic differentiation10.1039/c3ib40038g ↗
13. Bulk physicochemical, interconnectivity, and mechanical properties of calcium phosphate cements–fibrin glue composites for bone substitute applications10.1002/jbm.a.34342 ↗
14. Direct write assembly of calcium phosphate scaffolds using a water-based hydrogel10.1016/j.actbio.2009.06.031 ↗
15. Subcutaneous tissue response and osteogenic performance of calcium phosphate nanoparticle-enriched hydrogels in the tibial medullary cavity of guinea pigs10.1016/j.actbio.2012.10.026 ↗
16. Injectable calcium–phosphate-based composites for skeletal bone treatments10.1088/1748-6041/7/2/024113 ↗
17. Evaluation of the ultrasonication process for injectability of hydraulic calcium phosphate pastes10.1016/j.actbio.2011.10.032 ↗
18. Processing and in vivo evaluation of multiphasic calcium phosphate cements with dual tricalcium phosphate phases10.1016/j.actbio.2012.05.033 ↗
19. Calcium phosphate cements loaded with basic fibroblast growth factor: delivery and in vitro cell response10.1002/jbm.a.34390 ↗
20. The effect of amorphous pyrophosphate on calcium phosphate cement resorption and bone generation10.1016/j.biomaterials.2013.05.001 ↗
21. A new calcium phosphate water setting cement
22. Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement10.1002/jbm.1074 ↗
23. Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis10.1016/j.biomaterials.2003.10.049 ↗
24. Injectability of calcium phosphate pastes10.1016/j.biomaterials.2004.05.010 ↗
25. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites10.1089/ten.tea.2008.0694 ↗
26. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0 ↗
27. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility10.1016/j.biomaterials.2004.04.043 ↗
28. Calcium phosphate cements as bone drug delivery systems: a review10.1016/j.jconrel.2006.04.007 ↗
29. An injectable calcium phosphate–alginate hydrogel–umbilical cord mesenchymal stem cell paste for bone tissue engineering10.1016/j.biomaterials.2010.05.017 ↗
30. Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells10.1089/ten.tea.2011.0267 ↗
31. Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement–chitosan–RGD scaffold for bone repair10.1089/ten.tea.2012.0172 ↗
32. Endothelial cells derived from human embryonic stem cells10.1073/pnas.032074999 ↗
33. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells10.1089/scd.2008.0310 ↗
34. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications10.1089/ten.tea.2009.0629 ↗
35. Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs10.1634/stemcells.2006-0420 ↗
36. In vivo bone formation by progeny of human embryonic stem cells10.1089/scd.2009.0501 ↗
37. Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells10.1016/S1472-6483(10)60490-7 ↗
38. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent10.1038/nbt.1605 ↗
39. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons10.1634/stemcells.2007-0097 ↗
40. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells10.1089/ten.2004.10.1518 ↗
41. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells10.1073/pnas.0809680106 ↗
42. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d, l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds10.1016/j.biomaterials.2007.11.005 ↗
43. Endochondral bone tissue engineering using embryonic stem cells10.1073/pnas.0711662105 ↗
44. The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding10.1016/j.biomaterials.2010.03.065 ↗
45. Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering10.1016/j.actbio.2012.05.016 ↗
46. Platelet-rich plasma: evidence to support its use10.1016/j.joms.2003.12.003 ↗
47. Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres10.1016/j.biomaterials.2012.08.054 ↗
48. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation10.1016/j.tripleo.2008.06.023 ↗
49. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro10.1016/j.yjmcc.2009.03.011 ↗
50. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics10.1159/000095511 ↗
51. Comparison of platelet-rich plasma and VEGF-transfected mesenchymal stem cells on vascularization and bone formation in a critical-size bone defect10.1159/000337490 ↗
52. Strong and macroporous calcium phosphate cement: effects of porosity and fiber reinforcement10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X ↗
53. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects10.1016/j.biomaterials.2013.09.002 ↗
54. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method10.1006/meth.2001.1262 ↗
55. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks10.1021/bm900240k ↗
56. Platelet-released supernatant induces osteoblastic differentiation of human mesenchymal stem cells: potential role of BMP-210.22203/eCM.v020a33 ↗
57. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering10.1097/SCS.0b013e3181b09b7e ↗
58. Reconstruction of goat femur segmental defects using triphasic ceramic-coated hydroxyapatite in combination with autologous cells and platelet-rich plasma10.1016/j.actbio.2009.01.009 ↗
59. Platelet-rich plasma promotes angiogenesis of prefabricated vascularized bone graft10.1016/j.joms.2011.09.019 ↗
60. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous bone grafts and platelet rich plasma in goats10.1054/ijom.2003.0452 ↗
61. De novo bone formation using bovine collagen and platelet-rich plasma10.1016/j.biomaterials.2003.12.043 ↗
62. The effect of platelet-rich plasma on bone healing around implants placed in bone defects treated with Bio-Oss: a pilot study in the dog tibia10.1016/j.tripleo.2006.11.042 ↗
63. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study10.1016/j.ijom.2004.10.018 ↗
64. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts10.1902/jop.2007.070116 ↗
65. Platelet-rich plasmas: growth factor content and roles in wound healing10.1177/154405910508400507 ↗
66. The use of platelet-rich plasma in bone reconstruction therapy10.1016/j.biomaterials.2009.05.055 ↗
67. Coupling of osteogenesis and angiogenesis in bone substitute healing – a brief overview10.1016/j.aanat.2011.10.002 ↗
68. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits10.1016/S0142-9612(99)00280-X ↗
69. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels10.1016/S0142-9612(03)00168-6 ↗
70. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration10.1016/j.biomaterials.2006.01.033 ↗
71. Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?10.1002/stem.700 ↗